Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the template or formatting rather than changes to the study details.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3, indicating a small underlying update to the page. This change does not alter visible content or user-facing functionality.SummaryDifference0.0%

- Check42 days agoChange DetectedNew guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the recruitment status now indicates no participants are being sought. The Intervention/Treatment heading was updated and the revision tag bumped from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check49 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a small update to the page metadata; no study data or eligibility criteria are affected.SummaryDifference0.0%

- Check71 days agoChange DetectedA new 'Sample Collection' item was added and the page revision updated to v3.5.4; the previous version v3.5.3 was removed.SummaryDifference0.2%

- Check93 days agoChange DetectedUpdates the ClinicalTrials.gov page’s displayed revision identifier (e.g., version v3.5.2 to v3.5.3), reflecting a site/software release rather than a change to the trial record.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.